[Kyushu Tong: subsidiary amlodipine besylate tablets pass consistency Evaluation] Kyushu Tong announced that the subsidiary Beijing Jingfeng Pharmaceutical Group received a "notice of approval of Drug Supplementary Application" issued by the State Drug Administration, approving amlodipine besylate tablets (5mg) to pass the consistency evaluation of the quality and efficacy of generic drugs. Amlodipine besylate is an antihypertensive drug used in the treatment of essential hypertension, chronic stable angina pectoris and variant angina pectoris.